Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (17 quarters reported)
$254M in Q4 2020 → $56.8M now. Hover for any quarter.
As reported for the quarter ended December 31, 2024. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Annexon Inc | 66.9% | Unchanged | 7,406,024 | $38M |
| Akebia Therapeutics Inc | 19.2% | Unchanged | 5,747,906 | $10.9M |
| Verona Pharma PLC | 7.2% | Trimmed 57% | 88,000 | $4.09M |
| American Well Corp | 6.7% | Unchanged | 523,785 | $3.8M |
| AB Aadi Bioscience Inc | 0.0% | Unchanged | 659 | $2.08K |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended December 31, 2024 · filed February 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Verona Pharma PLC | Trimmed | −117,880 | −$5.47M | 7.2% |
quarter ended September 30, 2024 · filed November 13, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| American Well Corp | New | +523,785 | +$4.97M | 8.0% |
| American Well Corp | Exited | −10,475,717 | −$3.4M | — |
| AB Aadi Bioscience Inc | Trimmed | −1,630,171 | −$3.36M | — |
| Verona Pharma PLC | Trimmed | −7,120 | −$205K | 9.5% |
quarter ended June 30, 2024 · filed August 14, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Akebia Therapeutics Inc | Trimmed | −7,457,213 | −$7.61M | 11.5% |
| AT Aileron Therapeutics Inc | Exited | −830,466 | −$5.51M | — |
| Verona Pharma PLC | New | +213,000 | +$3.08M | 6.0% |
quarter ended March 31, 2024 · filed May 09, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Akebia Therapeutics Inc | Trimmed | −3,000,000 | −$5.49M | 25.4% |
quarter ended December 31, 2023 · filed February 09, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Assembly Biosciences Inc | Exited | −2,227,500 | −$1.97M | — |
| Annexon Inc | Added | +350,000 | +$1.59M | 44.7% |
quarter ended September 30, 2023 · filed November 13, 2023
No position changes this quarter.
quarter ended June 30, 2023 · filed August 14, 2023
No position changes this quarter.
quarter ended March 31, 2023 · filed May 15, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Annexon Inc | Added | +2,647,058 | +$10.2M | 35.9% |
| Akebia Therapeutics Inc | Added | +1,115,000 | +$625K | 12.0% |
Loading...
